Biosimilars/Biobetters Pipeline Directory        
The most comprehensive and cost-effective follow-on biopharmaceuticals (biosimilars, biobetters and biogenerics) pipeline resource 

  • Find competing products and companies; product/API licensing sources; collaborators and partners; customers for your products, technologies and services
  • Over 1,700 product records:  1,000+ biosimilars, 580+ biobetters, 155 reference products; plus 750+ involved company records [10/8/2018]
  • Available in database format:
    • Web database (Products and Companies) subscription - full online access and updates; plans for individuals and company-wide access
    • Directory/book/PDF format - upon purchase, delivery of a 1-time book-formatted version of current data
  • Developed by the author of BIOPHARMA:  Biopharmaceutical Products in the U.S. and European Markets, still the only information resource/reference specializing in biopharmaceuticals, but now archived as "The Reference Products' Reference."  This online database includes compiled and estimated patent and regulatory exclusivity expiration dates for all reference products. Ask about bundled discounts to the Pipeline and BIOPHARMA (Reference Products) databases.
  • Sales/fulfillment handled by BioPlan Associates, Inc.; Order/Inquiry
  • Satisfaction guaranteed!  Full refund within 1 month, e.g., if you do not learn information that critically affects your company.

Description/Flyer:  Further information
Users Guide
Enter password for database access: followed by CR/enter

Biosimilars/Biobetters Pipeline Database - Top Level Data (as of 10/1/2018)

  • product entries = 1,723
  • pipeline products (biosimilars + biobetters) = 1,566
  • biosimilars = 1,006
  • biobetters = 561
  • ref. products = 155
  • companies = 753
The Biosimilars/Biobetters Pipeline Directory covers only recombinant proteins (great majority) and other cell culture/fermentation-manufactured protein products (e.g., vaccines, blood/plasma and cellular products not included). 
[Note, biosimilar and biobetter U.S. and EU launchable dates (patent, data and market exclusivity expirations) are reported for the reference products in BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, "The Reference Products' Reference]." 

Near-term economic impact includes biosimilars sooner or later in the U.S. and European markets for the <50, nearly all recombinant, mostly monoclonal antibody, products with over $1 billion/year sales, and 20+ others with sales over $500 million/year. 

The table above shows country or regions and the numbers of biosimilars and biobetters associated with companies based (with headquarters) in these countries/regions.

Note, multiple companies are often involved with each product (developers, partners, licensees, etc.). Marketed products are here indexed by whether they appear primarily on track for initial or primary marketing in developed or developing country markets.

Some Popular Targeted Reference Products
[No. of biosimilars by reference product]
Epoetin alfa 94
Neupogen 67
Interferons (alfa) 117
Insulin and analogs 79
Rituxan 55
Herceptin 61
Humira 50
Avastin 50
Somatropins 42
Enbrel 38
Neulasta 34
Remicade 21
Lantus 17
Cancer indications 561
mAbs, mAb fragments      396

Companies With the Largest Biosimilars Pipelines (10 or more)

Harvest Moon Pharmaceuticals USA, Inc. 28
Bioviz Technologies Pvt. Ltd. 25
Pfizer 21
BioXpress Therapeutics S.A. 20
Reliance Life Sciences Pvt. Ltd. 19
Chemo Group (Grupo Insud ) 17
Mylan Labs. 17
Creative Biomart Inc. 15
Dong-A Pharmaceutical. 15
Inbiopro Solutions Pvt Ltd. 14
LG Life Sciences Ltd. 14
Dr. Reddy's Labs. 14
UGA Biopharma GmbH 14
Bio Sidus S.A. 14
Biocon Ltd. 13
BioPartners GmbH (Bioton) 13
Intas Biopharmaceuticals Ltd. 13
AXXO GmbH 12
Zhejiang HISUN Pharmaceuticals Co. Ltd./3S Bio. 12
Sandoz AG/Novartis AG 12
SciGen Ltd. (Bioton) 12
Amega Biotech 12
BioGenomics Ltd. 11
Green Cross Corp. 11
Zydus Cadilla Healthcare Ltd. 11
Viropro Inc. 11
Cassara Biotech 10
Biocad Biotechnological Co. 10
Siam Bioscience 10
Lupin Ltd. 10 Information Resources A variety of unique follow-on biopharmaceutical-related information resources are available or planned:

Some related articles by the database author:

Need a Consultant With Biosimilars Expertise? - Contact Biotechnology Information Institute for world-class expertise concerning biopharmaceutical information, products, technologies, and related market, technology and policy assessments.  

    Contact information: